The CORRECTX^™ platform enables the development of modular RNA binding protein systems that can modify RNA with multiple mechanistic approaches; cleavage, splicing, gene replacement, translation enhancement and editing. These systems offer unique features that address the limitations of other RNA targeted approaches and may lead to new genetic medicines for patients with neurodegenerative, neuromuscular and retinal diseases.